[go: up one dir, main page]

CA2919586A1 - Une composition pharmaceutique, utilisation d'une composition pharmaceutique et methode de traitement des symptomes d'exces de consommation d'alcool - Google Patents

Une composition pharmaceutique, utilisation d'une composition pharmaceutique et methode de traitement des symptomes d'exces de consommation d'alcool Download PDF

Info

Publication number
CA2919586A1
CA2919586A1 CA2919586A CA2919586A CA2919586A1 CA 2919586 A1 CA2919586 A1 CA 2919586A1 CA 2919586 A CA2919586 A CA 2919586A CA 2919586 A CA2919586 A CA 2919586A CA 2919586 A1 CA2919586 A1 CA 2919586A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
dose
group
symptoms
therapeutically effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2919586A
Other languages
English (en)
Inventor
Umjeet Jolly
Gilles Ethier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rise&shine Global Corp
Original Assignee
Rise&shine Global Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rise&shine Global Corp filed Critical Rise&shine Global Corp
Priority to CA2919586A priority Critical patent/CA2919586A1/fr
Publication of CA2919586A1 publication Critical patent/CA2919586A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/80Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/33Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Insects & Arthropods (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2919586A 2016-02-01 2016-02-01 Une composition pharmaceutique, utilisation d'une composition pharmaceutique et methode de traitement des symptomes d'exces de consommation d'alcool Abandoned CA2919586A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2919586A CA2919586A1 (fr) 2016-02-01 2016-02-01 Une composition pharmaceutique, utilisation d'une composition pharmaceutique et methode de traitement des symptomes d'exces de consommation d'alcool

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2919586A CA2919586A1 (fr) 2016-02-01 2016-02-01 Une composition pharmaceutique, utilisation d'une composition pharmaceutique et methode de traitement des symptomes d'exces de consommation d'alcool

Publications (1)

Publication Number Publication Date
CA2919586A1 true CA2919586A1 (fr) 2017-08-01

Family

ID=59485469

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2919586A Abandoned CA2919586A1 (fr) 2016-02-01 2016-02-01 Une composition pharmaceutique, utilisation d'une composition pharmaceutique et methode de traitement des symptomes d'exces de consommation d'alcool

Country Status (1)

Country Link
CA (1) CA2919586A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019043429A1 (fr) * 2017-08-28 2019-03-07 Bolona Gilbert Enrique Roberto Composition pharmaceutique orale pour la prévention et le traitement des symptômes causés par la consommation excessive de boissons alcoolisées, connus sous l'expression "gueule de bois"

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019043429A1 (fr) * 2017-08-28 2019-03-07 Bolona Gilbert Enrique Roberto Composition pharmaceutique orale pour la prévention et le traitement des symptômes causés par la consommation excessive de boissons alcoolisées, connus sous l'expression "gueule de bois"

Similar Documents

Publication Publication Date Title
JP4315687B2 (ja) カプサイシンを含有する乱用防止薬学的組成物
RU2492858C2 (ru) Композиции и способы профилактики и лечения зависимостей
US20030133951A1 (en) Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
US20070099947A1 (en) Methods and compositions for the treatment of brain reward system disorders by combination therapy
WO2007005716A2 (fr) Methodes de traitement et leurs compositions d'utilisation
US20040209850A1 (en) Methods of treating pain and compositions for use therefor
WO2007120485A2 (fr) Procédés de traitement de la douleur avec des alkylxanthines et des antiépileptiques et compositions à utiliser à cet effet
Engindeniz et al. Intramuscular tramadol vs. diclofenac sodium for the treatment of acute migraine attacks in emergency department: a prospective, randomised, double–blind study
US20240342156A1 (en) Methods for treating pain
KR20220113411A (ko) KV7 칼륨 채널 개방제(opener)의 통증 치료를 위한 용도
Patel et al. Opioids for pain after oral surgery
CA2919586A1 (fr) Une composition pharmaceutique, utilisation d'une composition pharmaceutique et methode de traitement des symptomes d'exces de consommation d'alcool
CA2893836C (fr) Combinaison medicamenteuse comprenant la phenylephrine et le paracetamol
Schumacher et al. Basic and clinical pharmacology
US7923453B1 (en) Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
ES2917618T3 (es) Tratamiento del alcoholismo y la depresión mediante el uso de ibudilast
US9238014B2 (en) Pharmaceutical composition for treating alcohol dependency
JPH0232020A (ja) モルフィン鎮痛治療における耐性発現の抑制方法および薬剤
Bloomfield et al. Guanadrel and guanethidine in hypertension
US8012990B2 (en) Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
Davison et al. Management of pain in renal failure
GB2510444A (en) Enhanced combination of phenylephrine and paracetamol
WO2013076339A1 (fr) Compositions et préparations combinées pour le traitement de la fibromyalgie
EP1940376B1 (fr) Utilisation de la neboglamine dans le traitement de la toxicodependance
US20250345324A1 (en) Combination formulations of naloxone and atipamezole

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190201

FZDE Discontinued

Effective date: 20190201